INTRODUCTION
Observations from several laboratories implicate degradation of matrix components as an important step in the development of osteoarthritis.
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In this respect, Bollet advanced the hypothesis that primary osteoarthritis might be perpetuated by abnormal exposure of underlying articular cartilage matrix to a normally occurring synovial fluid hyaluronidase introduced through surface abrasions (1) . He and his' collaborators found decreased hexosamine and uronate content as well as decreased polysaccharide chain-length in postmortem samples of osteoarthritic cartilage (2, 3) . They considered these findings to be evidence for enzymic degradation of the sugar moieties of cartilage matrix proteoglycans. Initiation of this process was postulated to include damage to cartilage cells from abnormal stresses, subsequent lysosomal protease release, and consequent tissue weakening and cartilage surface abrasion (1) . An enlarged zone of antigenic sites in osteoarthritic cartilage matrix reactive with fluoresceinlabeled antibodies to proteoglycans was shown by Barland, Janis, and Sandson (4); similarly, perichondrocytic halo zones were described by Chrisman (5) in osteoarthritic cartilage. Such data could be explained by chondrocytic enzymic degradation of local matrix proteoglycans. In recent years lysosomal protease rather than hyaluronidase activity became the chief suspected agent of this degradation. Thomas , McCluskey, Potter, and Weissmann (6) and the Dingle group (7, 8) gave the first clear demonstration that lysosomal protease(s) play a part in the degradation of embryonal chick cartilage matrix. They demstrated in organ cultures that excess vitamin A led to the release of lysosomal protease(s) and degradation of cartilage matrix. After that report, a growing body of evidence has pointed to lysosomal protease cathepsin D as a ubiquitous agent in causing degradation of cartilage matrices. Acid cathepsin activity resembling that of cathepsin D has been observed in bovine nasal and tracheal cartilage (9) and in bovine costal cartilage (10, 11) . Woessner (12) found that cathepsin D is the major protease in rabbit ear and in chick limb cartilage and that it can degrade cartilage even at neutral pH. Ali and Evans (13) concluded that in rabbit ear cathepsin D "is probably the most important cathepsin involved in the autolysis of cartilage at pH 5 .0." Ali also stated (13) that "in monkey articular cartilage cathepsin D may be the only acid protease responsible for cartilage degradation." Most recently Weston (14) prepared a specific antiserum to cathepsin D which inhibited autolytic degradation of cartilage, and Morrison (15) , concluded that "the major proteolytic activity in the degradation of cartilage matrix can be attributed to the lysosomal cathepsin D." In view of these significant developments concerning cathepsin D in animals, the present study was undertaken to investigate cathepsin D activity in human articular cartilage, especially in the early lesions of human osteoarthritis; to compare this activity with that of a highly purified cathepsin D prepared from the bovine uterus (16, 17) ; and to investigate the degradative action of these enzymes on proteoglycans, especially at neutral pH.
METHODS
13 patients, ages , all male, with symptomatic primary arthritis, grade II-IV by radiological criteria (18) provided the osteoarthritic cartilage samples for the current study. Five of these patients were undergoing surgery for total hip replacement or for debridement of a knee joint, and eight patients underwent diagnostic arthroscopy of a knee in lieu of a surgical exploration. All cartilage samples were taken from the knee and then only from nonweight-bearing sites subjected only to patellar pressures, viz., that portion of the articular surface exposed in the supracondylar fossa and the under surface of the patella itself. Control tissue was obtained from corresponding "normal" regions of the knee joints of the eight arthroscopy patients and from four additional patients, age 23-62. All of these additional patients were males, and revealed the following diagnoses: meniscal tear, 2 cases; and femoral arterial ischemia, requiring amputation of the involved extremity, 2 cases. Tissue from the knees of two patients with advanced vascular necrosis as judged by X ray and histological criteria were similarly studied. Patients were excluded from the current study if they had overt inflammatory joint disease or had received intra-articular corticosteroid administration within 2 wk before tissue sampling.
To select the biopsy sample, cartilage was viewed either directly or by means of the optical system of a Watanabe arthroscope, and samples 20-50 mg each wet wt, were dissected free, rinsed in 0.9% saline, patted dry on filter paper, and quick-frozen with an alcohol-acetone mixture. The samples were then thawed to 0-5OC and dissected with broken razor blades; samples were trimmed at X 50 magnification to conform to the following criteria based on gross appearance: (a) "normal", glistening white or pale yellow, resilient; (b) brown or dark yellow, nonfibrillated, and within 10 mm of an ulcerated osteoarthritic lesion (Fig. 1) subchondral bone. Samples (a) comprised the "control" and samples (b) the "discolored" samples used in this study. A small fragment of cartilage was saved for fixation, imbedding, and staining with fast green and safranin 0, and the remainder used for biochemical studies.
In a final group of experiments, patellar samples were obtained post-mortem from five 52 to 75-yr old males with osteoarthritis. These patellae were kept on ice, washed with cold physiological salt solution; subjected to dissection of cartilage, processed, and graded as described above for biopsy samples.
All the "discolored" cartilage samples in this study corresponded to grade 4-9 (average 6) osteoarthritic cartilage of Mankin, Dorfman, Lipiello, and Zarins (19) . The biopsy and postmortem patellar samples were used for enzyme studies and similarly graded surgery samples for the proteoglycan observations. Extraction of samples for enzyme studies. The cartilage was finely sliced and placed in a microglass homogenizer with 5 vol. 0.005 M phosphate buffer, pH 8.8. After letting stand in the buffer for 24 h at 4°C, the sample was homogenized by hand (in an ice bath) and then centrifuged at 20,000 g and 4°C. The supernate was removed and the pellet was extracted two times more in the same way. The supernates were combined and assayed for cathepsin D activity by the microassay described later. The resuspended pellet was also assayed.
Proteoglycan was extracted from similarly graded samples by the Sajdera-Hascall method (20) scaled down for 50 mg wet wt amounts of cartilage. The weight-average sedimentation coefficients(S) 1 of the proteoglycan was determined by the microtransport method of Pita and Muller (21) . The proteoglycan solution was diluted with 0.15 M aqueous KCl to 0.15 mg proteoglycan per ml. All S determinations in this study were carried out at this low concentration to avoid concentration dependence effects on the sedimentation coefficient (22) . 10 gl of the diluted solution was placed in a capillary cell (1.0 mm diameter and 1.2 mm long) and centrifuged in a swinging bucket type rotor in the Beckman model L preparative ultracentrifuge (62,000 g, 30 min) (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.). After centrifugation the solute boundary traversed a certain distance from the meniscus of the solution, placed 1 Abbreviations used in this paper: CPC, cetylpyridinium chloride; PGS, proteoglycan subunit; S, weight-average sedimentation coefficient.
at Xm cm from the rotor center. Then the microcell was sectioned through a previously marked plane on the glass surface, estimated to fall within the upper part of the plateau region. The length H of the column of solution in the upper (centripetal) section was measured. The concentration of proteoglycan in the solution, Co, as well as the initial loading concentration of the sample, C., were determined as uronate. The weight average sedimentation coefficient S was calculated through use of the formula S =-ln w2t
Cf Xm+ H Co which w is the angular speed used and t the centrifugation time. The error introduced by this method on the value of S is no more than twice the error in the analysis of the initial and final concentrations. When tested on proteins and proteoglycans of known S, the S values were within 5% of experimental error (21 previously described (16, 26) and concentrating by ultrafiltration on Amicon UM-10 membranes. It was 1,700-fold purified, had a specific activity of 120 U/mg protein, and contained the cathepsin D multiple forms 4-7 (26) with only a trace of other protein, as shown by disk electrophoresis. It had all the classical properties of cathepsin D (17) .
Microassay for cathepsin D. The modified Anson assay, previously described (17) , was reduced in volume. The incubation mixture consisted of 0.06 ml acid-denatured hemoglobin (1.5% wt/vol), pH 3.1, 0.02 ml enzyme extract and 0.02 ml 0.05 M citrate buffer, pH 3.1. Incubation was carried out in a 0.4 ml plastic centrifuge tube for 2 h at 370C.
After incubation 0.1 ml 10% trichloroacetic acid (TCA) was added, the mixture was let stand 15 min and then centrifuged in a microfuge (Beckman model 152) at 20,000 g. Tyrosine was determined by mixing 0.1 ml supernate, 0.2 ml 0.5 M NaOH, and 0.06 ml Folin-Ciocalteau reagent (diluted 1: 3 with water), letting stand 10 min and reading the absorbancy at 660 nm. For blanks, enzyme and substrate were incubated separately and were combined after addition of TCA. In the macroassay (17) 1 U of enzyme is defined as the amount of enzyme producing an absorbancy change of 1.0 at 660 nm. 1 U is equal to the release of 6.6 ueq tyrosine/h incubation, as determined by the absorbancy of a tyrosine standard. In the current study the microassay gave an absorbancy change of 20 for 1 U of enzyme, and therefore, absorbancy measurements were converted to enzyme units by dividing by 20 . For the average cartilage extract the assay was linear only up to 1 h incubation and only over the absorbancy range 0-0.25 (Fig. 2) pH activity curves were made using the microassay with both acid-denatured and urea-denatured hemoglobin in 0.2 M citrate buffer (pH 2-5.5) or phosphate buffer (pH 6-8).
The denatured hemoglobins were prepared as previously described (17 cult to obtain results, taken in conjunction with loss of normal staining for proteoglycan in similar samples indicated that degradation of proteoglycan occurred in these investigated cartilage samples in the marginal zone of the osteoarthritic lesion. Fig. 4 shows the pH curves of hemoglobin digestion given by two different groups of the biopsy sample extracts. The shape of these curves, the range of pH activity, and the pH maximum of 3.1 were characteristic of cathepsin D (16, 17) . These findings indicate that the hemoglobin digesting protease in the marginal human osteoarthritic samples was a cathepsin D-type enzyme.
The "normal" control or "clear" biopsy samples contained an average of 1 to 1.5 U of this cathepsin D activity per g wet wt. In contrast, the samples from the marginal zone of the osteoarthritic lesion contained two to three times as much activity (Table II) (Fig. 5) , using both acid-denatured and urea-denatured hemoglobin, like the pH curves of the biopsy samples, were characteristic of cathepsin D. They revealed a pH maximum of 3.1 with the aciddenatured and of 4.0 with the urea-denatured hemoglobin. These curves were very similar to the corresponding pH curves of the crude and the 1000-fold purified bovine uterus cathepsin D (17) , and of our most highly purified (single band on disk electrophoresis) bovine (16) pH 3.5-7 (with denatured enzyme) affected their sedimentation coefficient value only slightly, in a variable manner (0-12% decrease in S value). Both the human and the bovine enzymes digested the PGS maximally at pH 5.0 all the way down to a weight average S of about 2. Although both enzyme preparations had no action on hemoglobin at neutral pH, both degraded the PGS considerably at pH 7, breaking down the 18S PGS to a weight average S of 8-9 and the 15S PGS to a weight average S of about 7, under the given conditions (Fig. 6) . On 20 h incubation at pH 7, 1 U of the bovine cathepsin D degraded the 18S PGS further to uronatecontaining products with a weight average S of 6; and 1.5 U, to a weight average S of about 4.
The pH profiles of the 15S PGS obtained by the microviscometry (Fig. 7) for both the patellar and the purified bovine cathepsins paralleled that given by the sedimentation analysis. Again they revealed a pH maximum around 5 and also substantial degradation of the PGS in thle neutral pH range (pH 6.-7.5). Considerable degradation at neutral pH was demonstrated also by the viscometery at pH 7 with varying amounts of enzyme (Fig. 8) .
The viscometry (Fig. 8 ) and the sedimentation (Fig.   9 ) experiments showed that the degree of degradation of the PGS depended both on the amount of enzyme and the time of incubation. The PGS digestion by both the bovine and the human cartilage enzyme at neutral pH was exponential (Fig. 9 ). Even at neutral pH the degradation was comparatively fast; 1 U of the bovine cathepsin D was sufficient to degrade the PGS in 30mmr to 70% of its original specific viscosity and to 60% of its initial S value.
The human cartilage enzyme extract also degraded a sample of protein-polysaccharide complex (PPC, kindly supplied by Dr. Lawrence Rosenberg of New York University) from an S value of 33.7 to pieces of 9.5S after 20 h incubation at pH 7. The PGS digestion at pH 7 by the human cartilage enzyme extract (Table III) acetamidle which inhibits cathepsin A and B, nor by cysteine which activates these cathepsins. Nor was it inhibited by diisopropylfluorophosphate (DFP) which inhibits several neutral proteases (32, 39, 40) . These reagents had no effect on the PGS degradation also at pH 4.5. On the other hand, chloroquine inhibited the PGS digestion quite considerably at neutral pH (Table  III) .
DISCUSSION
The term cathepsin D refers to a class of very closely related acid cathepsins which digest acid-denatured hemoglobin maximally at pH 3.0-3.5 and urea-denatured hemoglobin around pH 4.0 and are not affected by sulfhydryl and serine reagents (17) . Cathepsin D does not hydrolyze the usual small synthetic peptides but digests the B chain of insulin with a specificity closely related to that of pepsin. Quite a number of enzyme preparations, including some highly purified ones, have been identified as cathepsin D-type enzymes chiefly by their pH activity curves, without testing their specificity on B chain of insulin (27, 43, 44) . In fact, de Duve, Wattiaux, and Bandhuin (45) and Woessner (46) have suggested that any lysosomal acid cathepsin degrading hemoglobin around pH 3.5 is probably cathepsin D.
The acid cathepsin reported here in the human articular cartilage is undoubtedly a cathepsin D-type enzyme. The size and shape of the pH activity profile, the narrow pH range, and lack of effect by iodoacetamide on the hemoglobin digestion as well as lack of effect of cysteine and DFP on its action on proteoglycan are suggestive that this cathepsin D-type enzyme may be the major hemoglobin and proteoglycan-digesting protease in the human cartilage studied here. Woessner (46) found that cathepsin D accounts for almost all the hemoglobin- (16, 48) , and more specificially, a pronounced rise in the content of cathepsin D has been found in a variety of species at tissues sites wherein connective tissue is in the transitional state of remodelling (49) . Therefore, it was not surprising to find in the early lesions of human osteoarthritis and in the discolored patellar samples tested a two-to threefold increase in cathepsin D-type enzyme. Likewise, Ali 2 (58) . However, here it inhibited degradation of PGS in a particulate-free system (Table III) . Chloroquine at pH 7 is a doubly protonated cation and may inhibit by binding to the negatively charged PGS in a way similar to its binding to DNA (59) . In any event, and whether contamination by a neutral protease is involved or not, chloroquine inhibited the degradation of PGS at neutral pH.
